Latest Medical Research News and Research
Updated: 53 min 54 sec ago
Biologic therapy for IBD patients through a financial assistance program could have superior outcomes
Patients with inflammatory bowel diseases (IBD) who required treatment with biologic therapies and were enrolled in a financial assistance program were less likely to need surgery after starting medication than those not enrolled in a program, a study by UT Southwestern researchers found.
More than two years into the pandemic, multiple analyses of federal, state and local data show that people of color were, and continue to be, disproportionately impacted by COVID-19.
The majority of people living with Long Covid experience some form of stigma directly related to their condition, according to a new study published in the journal PLOS ONE.
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.
Teens and young adults who are treated for sleep disorders with benzodiazepines such as Xanax – a medication commonly prescribed to treat anxiety and insomnia – may be at a higher risk of overdose, according to Rutgers researchers.
VTC scientist wins $2.7 million to investigate viral infection of the heart that can cause sudden death
James Smyth, associate professor at the Fralin Biomedical Research Institute at VTC, has been awarded a five-year, $2.7 million grant from the National Institutes of Health to discover why viruses that normally infect our lungs can turn deadly when they infect the heart.
A vaping habit could end up leading to a tarnished smile, and more frequent visits to the dentist.
The sense of touch is essential to almost everything we do, from routine tasks at home to navigating unfamiliar terrains that may conceal dangers.
Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant.
Researchers at the University of São Paulo in Brazil have found that severe COVID-19 is associated with an imbalance in an important immune system signaling pathway.
Patients who take statins to lower high cholesterol levels often complain of muscle pains, which can lead them to stop taking the highly effective medication and put them at greater risk of heart attack or stroke.
A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells.
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers.
MiRNAs can be used as a biomarker to predict disease recurrence and mortality in breast cancer patients
Researchers at University of Galway have determined that biomarkers known as microRNAs can help predict which patients with breast cancer are likely to face a recurrence of the disease and death.
By measuring immune cells in the cerebrospinal fluid when diagnosing ALS, it is possible to predict how fast the disease may progress according to a study from Karolinska Institutet published in Nature Communications.
Maternal obesity during pregnancy causes metabolic perturbations in offspring's liver and skeletal muscle
A recent study in The FASEB Journal has identified metabolic perturbations in the liver and skeletal muscle of young nonhuman primates on normal diets whose mothers were obese during pregnancy.
In a study published in Arthritis & Rheumatology that included nearly 1.3 million men aged 20–39 years who participated in three serial health check-ups at two-year intervals, men with metabolic syndrome (MetS) and those who developed MetS-;especially those with the MetS components of elevated triglycerides and abdominal obesity-;had higher risks of developing gout.
For the first time, a new study has identified enlarged perivascular spaces in the brains of migraine sufferers. Results of the study will be presented next week at the annual meeting of the Radiological Society of North America.
Researchers performed in vitro experiments to test the ability of different frequencies of ultrasound to inactivate SARS-CoV-2.
Researchers have identified a protein that, when present in high amounts in breast cancer tumors, is an indicator of whether DNA-damaging therapies will work or not.